Corcept Therapeutics Incorporated (CORT)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	106,140	91,386	94,616	94,500	101,418	116,870	112,733	111,844	112,512	106,453	97,607	99,411	106,011	109,398	114,113	105,972	94,181	86,808	78,215	76,225
Total assets	US$ in thousands	621,517	594,022	524,625	617,848	583,430	533,255	496,364	468,123	423,756	585,399	568,480	552,398	571,731	534,125	497,823	445,494	412,312	367,022	328,679	320,212
ROA		17.08%	15.38%	18.03%	15.30%	17.38%	21.92%	22.71%	23.89%	26.55%	18.18%	17.17%	18.00%	18.54%	20.48%	22.92%	23.79%	22.84%	23.65%	23.80%	23.80%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $106,140K ÷ $621,517K
= 17.08%

Corcept Therapeutics Inc's return on assets (ROA) has shown some fluctuations over the past eight quarters. The company's ROA ranged from a low of 15.30% in Q1 2023 to a high of 23.89% in Q1 2022. Overall, the ROA trend indicates that the company has been effectively utilizing its assets to generate profits, with an average ROA of approximately 18.47% over the period analyzed. These results suggest that Corcept Therapeutics Inc has been successful in generating earnings relative to its total assets, although there has been some variability in performance. It may be beneficial for stakeholders to further investigate the factors contributing to these fluctuations to ensure sustained financial health and profitability.